Published on 1 Nov 2023 on GuruFocus.com via Yahoo Finance
Avanos Medical Inc (AVNS) Reports Q3 2023 Earnings: Net Sales Dip by 0.6%
Avanos Medical Inc (NYSE:AVNS) reports Q3 2023 net sales of $171.3 million, a decrease of 0.6% from the prior year period.The company's net loss from continuing operations for the quarter was $8.8 million, compared to net income from continuing operations of $11.0 million a year ago.Adjusted net income from continuing operations totaled $14.0 million, compared to $11.5 million a year ago.Free cash flow for the quarter exceeded $25 million.
Warning! GuruFocus has detected 3 Warning Signs with AVNS.
On November 1, 2023, Avanos Medical Inc (NYSE:AVNS) released its third quarter 2023 financial results. The company reported a slight decrease in net sales from continuing operations, which totaled $171.3 million, a 0.6% decrease from the comparable prior year period. The net loss from continuing operations for the quarter was $8.8 million, compared to net income from continuing operations of $11.0 million a year ago.